期刊文献+

Ⅲ型干扰素的抗肿瘤作用

Anti-tumor effect of type Ⅲ interferon
原文传递
导出
摘要 研究发现Ⅲ型干扰素(IFN-λ)具有抗黑色素瘤、肝细胞癌、食管癌、纤维素瘤等的作用。IFN-λ不仅能抑制黑色素瘤的转移,还可引起细胞凋亡;组成性表达的IFN-λ使自然杀伤细胞活化,从而影响肝细胞癌的生长;在食管癌中,IFN-λ能诱导G-期细胞的停滞或直接导致细胞凋亡;IFN-λ入可通过诱导固有免疫和适应性免疫反应来抑制体内纤维肉瘤的生长。这些抗肿瘤机制的研究为IFN-λ运用于肿瘤临床治疗提供了新的思路。 It is reported that type m interferon (IFN-λ) has an anti-tumor effect on melanoma, hepa- tocellular carcinoma, esophageal carcinoma and fibrosarcoma in recent years. IFN-λ could not only inhibit mel- anoma metastasis, but also induce cell apoptosis ; its constitutively expression could activate natural killer ceils, affecting hepatocellular carcinoma growth; IFN-λ. could induce cells of G1 phase in esophageal carcinoma directly to stagnation or apoptosis; IFN-λ could cause native and adaptive immune response to suppress fibrosarcoma growth. Research on the anti-tumor mechanisms of IFN-λ will provide new ideas for clinical tumor therapy.
出处 《国际肿瘤学杂志》 CAS 2012年第12期905-907,共3页 Journal of International Oncology
基金 国家自然科学基金资助项目(30972754) 教育部留学回国人员科研启动基金资助项目[教外司留(2010)609号]
关键词 干扰素类 肿瘤 Interferons Neoplasms
  • 相关文献

参考文献15

  • 1Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. Interferon Cytokine Res, 2010, 30(8) : 555-564.
  • 2Lasfar A, Lewis-Antes A, Smirnov SV, et al. Characterization of the morose IFN-lambda ligand-receptor system : IFN-lambttas exhibit anti- tumor activity against B16 melanoma. Cancer Res, 2006, 66 (8) : 4468 -4477.
  • 3Guenterberg KD, Grignol VP, Raig ET, et al. Interleukin-29 binds to melanoma eells inducing Jak-STAT signal transduction and apoptosis. Mol Cancer Ther, 2010, 9(2):510-520.
  • 4Sate A, Ohtsuki M, Hata M, et al. Antitumor activity of IFN-λ in murine tumor models. J Immunol, 2006, 176( 12) : 7686-7694.
  • 5Abushahba W, Balan M, Castaneda I, et al. Antitumor activity of type Ⅰ and type Ⅲ interferons in BNL hepatoma mode/. Cancer hnmunol hnmunother, 2010, 59 (7) : 1059-1071.
  • 6Ren S, Lu J, Du X, et ah Genetic variation in Ⅱ28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunol Imnmnother, 2012, 61 ( 9 ) : 1433-1439,.
  • 7Li Q, Kawamura K, Ma G, et al. Interferon-k induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti- turnout effects in combination with anticancer agents. Eur J Cancer, 2010, 46(1) : 180-190.
  • 8Li Q, Kawamura K, Okamoto S, et al. Adenovinises-med+ated trans- duction of human oesophageal carcinonm cells with the interferon-k genes produced anti-turnout effects. Br J Cancer, 2011, 10S (9) : 1309-1312.
  • 9Numasaki M, Tagawa M, Iwata F, et al. IL-28 elicits anti-tumor responses against murine fibrosarcoma. J Immunol, 2007, 178 (8) : 5086-5098.
  • 10Meager A, Visvalingam K, Dilger P, et al. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cyto- kine, 2005, 31(2): 109-118.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部